Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...
A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...
Scientists from UC Davis Center for Surgical Bioengineering, the MIND Institute and UC Berkeley’s Murthy Lab are developing ...
Genetic disorders occur due to alterations in the primary genetic material—deoxyribonucleic acid (DNA)—of an organism.
The need to change regulations around gene-editing treatments was endorsed in November by the head of the US Food and Drug ...
The Phase 1/2 trial is a first-in-human, open-label, multi-national study designed to evaluate the safety, tolerability, and efficacy of TSRA-196 in adults with AATD. Trial participants will receive a ...
Picture CRISPR-Cas9, a gene editing technology, as a GPS-guided scalpel: gRNA directs the Cas9 enzyme, a protein that cuts ...
Gene editing is rewriting the future of medicine, as seen in the case of a baby named KJ Muldoon who got a fully personalised ...
Quest to beat the US saw a Chinese team turn to ancient traditions, leading to a new technique 10 times more effective than ...
Like other developing countries, Indonesia is facing a familiar dilemma: how to feed a growing population while protecting ...
As CRISPR moves from lab success to real-world medicine, 2026 will test whether these revolutionary gene-editing therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback